PTN
PALATIN TECHNOLOGIES INC
Key Financials
Net Income
$-17307349
↑ 41.8%
Operating Income
$-17459939
↑ 22.4%
EPS (Diluted)
$-32.15
↑ 68.2%
Total Liabilities
$8.0M
↓ 25.9%
Shareholders' Equity
$-4777045.00
↓ 4184.5%
Long-term Debt
$0.00
↓ 100.0%
Revenue
$12.9M
N/A
Total Assets
$3.3M
↓ 69.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEF 14A | 6/25/2026 | View on SEC |
| CERT | 5/28/2026 | View on SEC |
| 8-A12B | 5/28/2026 | View on SEC |
| 25 | 5/28/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| SCHEDULE 13G | 4/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PTN |
| Company Name | PALATIN TECHNOLOGIES INC |
| CIK | 911216 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | NJ |
| Phone | 609-495-2200 |